Authored by Darren R. Jones, Michael K. Green, Mark Scallon, David A. Gregory, Grace Macalino, Arun Parekkat, Samantha Sutherland, Timothy J. Nugent

Baker Tilly’s outlook on what lies ahead for industry leaders

As we progress into 2024, it’s evident that the life sciences industry has proven to be highly resilient. This past year has been stable for life sciences whereas other industries have struggled with rapidly evolving economic challenges. Despite the ongoing success of the life sciences industry, there will be obstacles for organizations to face. This year, success will be dictated by how industry leaders tackle these adversities. 

To assist life sciences organizations in formulating and implementing their strategic initiatives for 2024, Baker Tilly’s team of life sciences specialists has compiled a list of key developments that leaders should consider. The complimentary whitepaper discusses: 

• Trends and challenges in the healthcare market 
• Increases in capital market activity 
• Navigating the compliance and regulatory landscape 
• Market access and the importance of data utilization 
• U.S. government pricing updates 
• Medical affairs and patient access 
• Developments within the European, Middle East, and Africa (EMEA) as well as Asian-Pacific (APAC) markets 
• And more

Download the full report now

For more insights, visit Baker Tilly’s life science’s page. 

Baker Tilly

Baker Tilly

Baker Tilly US, LLP (Baker Tilly) is a leading advisory CPA firm, providing clients with a genuine coast-to-coast and global advantage in major regions of the U.S. and in many of the world’s leading financial centers – New York, London, San Francisco, Los Angeles, Chicago and Boston. Baker Tilly is an independent member of Baker Tilly International, a worldwide network of independent accounting and business advisory firms in 141 territories, with 43,000 professionals and a combined worldwide revenue of $5.2 billion. Visit bakertilly.com or join the conversation on LinkedIn, Facebook and Instagram.

More from Baker Tilly